{"id":"W2810908182","doi":"10.1093/rheumatology/key161","title":"Ixekizumab improves patient-reported outcomes up to 52 weeks in bDMARD-naïve patients with active psoriatic arthritis (SPIRIT-P1)","year":2018,"lang":"en","type":"article","venue":"Lara D. Veeken","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Dermatology Life Quality Index; Quality of life (healthcare); Psoriatic arthritis; Visual analogue scale; Placebo; Physical therapy; Randomized controlled trial; Adalimumab; Psoriasis; Internal medicine; Arthritis; Dermatology; Alternative medicine; Secukinumab; Rheumatoid arthritis; Nursing","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00007155754,0.0004127823,0.0008107877,0.0002243261,0.0001807095,0.00003954335,0.0001103228,0.000137056,0.0001396978],"category_scores_gemma":[0.0002241727,0.0003241987,0.0001294665,0.0004545811,0.0001317159,0.0001919493,0.0001365051,0.0002140651,0.0001818588],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000249711,"about_ca_system_score_gemma":0.0000962251,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008142135,"about_ca_topic_score_gemma":0.001783577,"domain_scores_codex":[0.9974464,0.00004583217,0.0005770434,0.0006656693,0.0005860845,0.000678996],"domain_scores_gemma":[0.9985093,0.00006460533,0.0002152432,0.0005871688,0.0003487477,0.0002749038],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002174886,0.001070945,0.5339651,0.00003297366,0.0008273647,0.0004478404,0.004353255,5.512815e-7,0.0000527764,0.00003446911,0.001204644,0.4558352],"study_design_scores_gemma":[0.01712819,0.005612202,0.9685768,0.0003476145,0.000160905,0.00002341178,0.0007558533,0.000005277413,0.0006662958,0.00008278314,0.006267673,0.0003729605],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944521,0.0002437638,0.00001071114,0.0006748061,0.0007755694,0.001742978,0.000100041,0.00009688511,0.001903137],"genre_scores_gemma":[0.9972366,0.00005523426,0.0005706815,0.0009664925,0.0001509669,0.0002770539,0.0001221042,0.00006653125,0.0005543352],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4554622,"threshold_uncertainty_score":0.999921,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.009726416930599485,"score_gpt":0.2563117587907305,"score_spread":0.2465853418601311,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}